Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3CNS 2Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 8Prostatic Neoplasms 7Ovarian Neoplasms 6Breast Neoplasms 6Carcinoma, Transitional Cell 5Stomach Neoplasms 4Pancreatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Neoplasms 3Neoplasm Metastasis 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Tumor Virus Infections 1Thrombocytosis 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrent Bladder Urothelial Carcinoma 1Recurrence 1

Interventions

X-Rays 6Phantoms, Imaging 6Filgrastim 6Cyclophosphamide 6Carboplatin 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Ifosfamide 5Temozolomide 4Nuclear Medicine Department, Hospital 4Gemcitabine 4Etoposide 4Granulocyte Colony-Stimulating Factor 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ixabepilone 2ivosidenib 2etoposide phosphate 2ensartinib 2cabozantinib 2belinostat 2Vincristine 2Vemurafenib 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Albumin-Bound Paclitaxel × Genitourinary × Clear all
NCT03507491 2024-10-04

Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors

Emory University

Phase 1 Completed
24 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡